WallStSmart

Amrize Ltd (AMRZ)vsEagle Materials Inc (EXP)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Amrize Ltd generates 427% more annual revenue ($12.26B vs $2.32B). EXP leads profitability with a 17.3% profit margin vs 10.2%. AMRZ appears more attractively valued with a PEG of 1.22. AMRZ earns a higher WallStSmart Score of 62/100 (C+).

AMRZ

Buy

62

out of 100

Grade: C+

Growth: 4.0Profit: 6.5Value: 5.7Quality: 5.0
Piotroski: 2/9Altman Z: 1.61

EXP

Buy

57

out of 100

Grade: C

Growth: 3.3Profit: 8.5Value: 4.7Quality: 6.5
Piotroski: 3/9Altman Z: 2.24
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for AMRZ.

EXPSignificantly Overvalued (-54.2%)

Margin of Safety

-54.2%

Fair Value

$148.98

Current Price

$186.04

$37.06 premium

UndervaluedFair: $148.98Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AMRZ2 strengths · Avg: 8.0/10
Price/BookValuation
1.8x8/10

Reasonable price relative to book value

Operating MarginProfitability
21.2%8/10

Strong operational efficiency at 21.2%

EXP3 strengths · Avg: 8.3/10
Return on EquityProfitability
28.7%9/10

Every $100 of equity generates 29 in profit

P/E RatioValuation
14.3x8/10

Attractively priced relative to earnings

Operating MarginProfitability
21.7%8/10

Strong operational efficiency at 21.7%

Areas to Watch

AMRZ4 concerns · Avg: 3.8/10
Revenue GrowthGrowth
2.2%4/10

2.2% revenue growth

EPS GrowthGrowth
4.1%4/10

4.1% earnings growth

Altman Z-ScoreHealth
1.614/10

Distress zone — elevated risk

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

EXP4 concerns · Avg: 3.5/10
PEG RatioValuation
2.094/10

Expensive relative to growth rate

Revenue GrowthGrowth
2.6%4/10

2.6% revenue growth

Debt/EquityHealth
1.213/10

Elevated debt levels

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : AMRZ

The strongest argument for AMRZ centers on Price/Book, Operating Margin. PEG of 1.22 suggests the stock is reasonably priced for its growth.

Bull Case : EXP

The strongest argument for EXP centers on Return on Equity, P/E Ratio, Operating Margin. Profitability is solid with margins at 17.3% and operating margin at 21.7%.

Bear Case : AMRZ

The primary concerns for AMRZ are Revenue Growth, EPS Growth, Altman Z-Score.

Bear Case : EXP

The primary concerns for EXP are PEG Ratio, Revenue Growth, Debt/Equity.

Key Dynamics to Monitor

EXP is growing revenue faster at 2.6% — sustainability is the question.

AMRZ generates stronger free cash flow (431M), providing more financial flexibility.

Monitor BUILDING MATERIALS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

AMRZ scores higher overall (62/100 vs 57/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Amrize Ltd

BASIC MATERIALS · BUILDING MATERIALS · USA

Amrize Ltd (AMRZ) is an innovative technology firm at the forefront of the digital health and wellness industry, dedicated to transforming healthcare delivery with cutting-edge technologies and data-driven solutions. The company prioritizes enhancing patient outcomes and access to care, significantly investing in research and development to address the rising demand for scalable health innovations. With a diverse portfolio of products and strategic initiatives, Amrize is well-positioned to become a critical player in the ongoing evolution of healthcare, presenting a compelling investment opportunity for institutional investors navigating a dynamic market.

Visit Website →

Eagle Materials Inc

BASIC MATERIALS · BUILDING MATERIALS · USA

Eagle Materials Inc., produces and supplies heavy construction materials, lightweight construction materials and materials used for the extraction of oil and natural gas in the United States. The company is headquartered in Dallas, Texas.

Want to dig deeper into these stocks?